Publicly Accessible Expert Information Service (VPOIS)
Information about medicinal products for professionals and the public
You have entered a publicly accessible area that contains information about all products of VUAB Pharma a.s. registered in the Czech Republic. The obligation to establish this "Publicly Accessible Expert Information Service – VPOIS" arises from Act No. 378/2007 Coll. as amended (Section 33, paragraph 3, letter g, point 1).
Current information about the products of VUAB Pharma a.s. can be found on the website of the State Institute for Drug Control.
Information from the Summary of Product Characteristics (SPC) is intended for healthcare professionals
For the general public, the information from the package leaflet (PIL).
Thiopental VUAB inj. plv. sol. 0.5 g
Thiopental VUAB inj. plv. sol. 1.0 g
Suxamethonium chloride VUAB 100 mg
Suxamethonium chloride VUAB 50 mg / ml
_
All the listed products, except for Suxamethonium chloride VUAB 50 mg/ml, are available on the Czech market.
If you have a different inquiry, please use the section Documents for download. We recommend that patients contact their respective attending physician with questions regarding their treatment and prescribed medicinal products.
Suspected adverse effects and further information on the safety of VUAB Pharma a.s. medicinal products can also be reported by email: safety@pharma-service.cz or by phone: +420 777 188 722 (or +420 775 635 403).
If your inquiry is urgent, please contact your doctor or the emergency medical service.
Czech quality for better health worldwide
The excellent reputation that VUAB Pharma a.s. has earned in the field of the pharmaceutical industry is based on its tradition, experience, and responsible approach to employees.
About us